
Teva reaches $100M settlement with Rhode Island for decade of anti-narcotic drugs and $21M cash
Kåre Schultz, the top dog at Teva Pharmaceuticals, said last month on a Q4 call that the pharma giant was confident it could reach a nationwide settlement over its role in the US opioid epidemic within a year’s time.
While today is not that day, Teva can add one more state to the list of settlements the company has reached with individual states.
The pharma announced yesterday that Teva’s US subsidiary and Rhode Island attorney general Peter Neronha reached an agreement that would settle all of the state’s claims against Teva related to the generic player’s role in the US opioid epidemic.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.